Live Updates > Live Update Details
2025-09-14 11:23:59
[The increase in US tariffs has caused fluctuations in Italy's pharmaceutical exports] 1. The United States recently imposed a 15% "reciprocal tariff" on most EU goods exported to the United States, and Italy's pharmaceutical industry exports are facing a significant impact. As one of Italy's industries with the highest added value in exports to the United States, pharmaceutical and chemical products have huge annual exports-it is expected to export to the United States about 10 billion euros (about 83.6 billion yuan) in 2024. After the new tariffs take effect, the industry's costs are expected to increase by up to 1.95 billion euros (about 16.3 billion yuan), and this part of the cost is likely to be passed on to the downstream market. 2. The European Federation of Pharmaceutical Industries and Associations pointed out that tariffs are like "blunt weapons". In markets such as pharmaceuticals with strict regulations and rigid demand, price increases may affect the confidence of American distributors and patients, bringing further uncertainty.
